After FDA approval for children 6 and older, ADA data show inhaled insulin's safety and satisfaction benefits, but clinician ...
The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...
Men and urban minority patients with early-onset CRC face elevated CVD death risk, highlighting gaps in survivorship care and ...
Mixed κ agonism and μ antagonism/partial agonism raises mechanistic and abuse-liability questions, with nausea, vomiting, ...
Tune-401 achieved dose-dependent HBsAg reductions (mean 54% at 0.65 mg/kg) with durable, months-long pharmacodynamics after single dosing on stable nucleos(t)ide analog background. Multiple recipients ...
The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...
Ajai Chari, MD, unpacks resistance mechanisms, treatment sequencing, and why myeloma’s future may be brighter than anyone ...
Objective: To compare the real-world effects of weekly injectable semaglutide (Ozempic) vs dulaglutide (Trulicity) on weight ...
SEER-Medicare data (n=54,344; mean age 77.7 years) showed significant unadjusted Black-White gaps in localized diagnosis, ...
Among those who received a prior authorization denial, 41% said it delayed their medical care, and 28% said their health ...
The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...
OLYMPIA-3 trial at ASCO 2026 shows odronextamab plus CHOP in higher-risk B-cell lymphoma delivers strong MRD-negative CRs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results